Italian Minister of Health for the care of patients with dementia ("CRONOS project," www.Alzheimer-cronos. org). 10 These units (ie, SCU, GERU-D, and AEUs) have different goals and different patient selection criteria, with different clinical settings. The SCUs are located in nursing homes and admit patients with severe dementia with BPSD who cannot return home. The GERU-D are located in rehabilitation facilities outside of hospitals and are designed for patients with dementia who may return home but have transient (moderate or severe) BPSD, not manageable at home, including delirium or any other problem requiring a close somatic assessment or emergency care. The AEUs are located in hospitals for out-patients who have dementia and stable clinical conditions, although they might require pharmacological treatments for BPSD.
In the Lombardia region, GERU-Ds are settings comparable to French CBUs. Data available from a study in this context 9 suggest that GERU-Ds are capable of effectively addressing patients' clinical needs without causing extra burden to caregivers. Indeed, a high proportion of patients are directly admitted from home (80%) and discharged to home (78%) after a significant improvement of BPSD (Neuropsychiatric Inventory, average score, SD 23.1 ± 16.5 and 14.5 ± 14.9 on admission and at discharge, respectively). In addition, reduction of BPSD without increasing the use of neuroleptics or sedatives was a relevant finding from this study. Further research is, however, warranted to assess GERU-D effectiveness including a control group in a randomized design.
In conclusion, the data from the French and Italian experiences do not allow drawing inferences about the opportunity to incorporate these units into a care network for patients with dementia. Nonetheless, both these models attempt to provide comprehensive care for patients with severe BPSD and can therefore be considered as potential avenues for research and development to address this important health care issue.
